Shop by goal

Popular compounds

GHK-Cu

Retatrutide

Research resources

Certificates of Analysis

IGF-1 LR3: Muscle / Performance research guide

Q: What is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino-acid analogue of human IGF-1 with an N-terminal extension and an Arg substitution at position 3. Those modifications stop it binding IGF-binding proteins, greatly extending its active half-life versus native IGF-1. It is supplied as a lyophilised research-grade powder for laboratory use only.

Q: What does IGF-1 LR3 do?

In research models IGF-1 LR3 activates the IGF-1 receptor (and PI3K/Akt and MAPK signalling) to drive cell growth, proliferation, differentiation and survival — with a much longer duration of action than native IGF-1 because it evades IGFBP sequestration. These are findings in cell and animal models; New-U supplies it for laboratory research only and implies no human effect.

Q: What is IGF-1 LR3 used for?

IGF-1 LR3 is widely used as a cell-culture supplement to support proliferation and survival of cultured cells, and as a research tool for studying IGF-1-receptor signalling, hypertrophy and tissue-growth endpoints. New-U supplies it strictly for in-vitro and laboratory research; it is not for human use.

Q: Does IGF-1 LR3 show up on a drug test?

Standard employment or clinical drug panels (including typical LabCorp steroid panels) do not screen for IGF-1 LR3 — it is a peptide, not a small-molecule steroid, and requires specialised assays. It is, however, on the WADA Prohibited List, and anti-doping authorities use dedicated tests for IGF-1 analogues. New-U supplies IGF-1 LR3 for laboratory research only, not for human or athletic use.

Q: What does "LR3" actually mean?

"L" for the 13-amino-acid N-terminal extension (MFPAMPLSSLFVN), "R" for arginine, and "3" for position 3 of the IGF-1 sequence. So "LR3" literally means "the Long variant with an Arginine at position 3". Both modifications are needed to eliminate IGFBP binding and extend circulating half-life.

Q: How is IGF-1 LR3 different from IGF-1 DES?

IGF-1 DES is the opposite end of the design spectrum - a truncated 67-residue form missing the N-terminal tripeptide GPE, which also dramatically reduces IGFBP binding. IGF-1 LR3 uses a 13-residue extension to achieve similar IGFBP resistance. LR3 has a much longer half-life (20-30 h vs minutes); DES produces more intense, shorter-duration local effects when injected site-specifically.

Q: Why is IGF-1 LR3 used in cell culture?

Native IGF-1 is inefficient in cell culture because IGFBPs produced by the cells themselves can sequester it, reducing effective concentrations. IGF-1 LR3 escapes that sequestration and delivers consistent, reproducible growth-factor signalling. That is why it is an industry standard for bioprocessing and mammalian cell culture.

Q: How should IGF-1 LR3 be stored?

Keep the lyophilised powder frozen at −20 °C (−80 °C for long-term storage). After reconstitution, refrigerate at 1-6 °C and protect from light. IGF-1 LR3 is a structured protein and is sensitive to repeated freeze-thaw cycles - aliquot if you need multiple aliquots from one reconstitution.

Q: How is IGF-1 LR3 reconstituted in the lab?

Because IGF-1 LR3 is a structured protein that tends to aggregate in neutral aqueous solution, laboratory practice commonly reconstitutes it in dilute acetic acid (around 0.1%, ~10 mM) rather than plain water, which keeps it in a non-aggregated state; bacteriostatic or sterile water is also used. The vial is allowed to reach room temperature before opening to avoid condensation, then gently rolled rather than shaken. This is general handling guidance for research material, not a dosing instruction.

Q: Is this page medical advice? Can I use IGF-1 LR3 for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

In short: IGF-1 LR3, 83-amino acid extended IGF-1 analogue with Arg3 substitution eliminating IGFBP binding for 3-fold enhanced potency and 20–30 hour half-life. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. IGF-1 LR3 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

IGF-1 LR3 at a glance

Compound type

Research peptide

Research category

Muscle / Performance

Also known as

Long R3 IGF-1, Long Arginine 3 IGF-1, IGF-1 LR3, LR3-IGF-1, Insulin-Like Growth Factor 1 Long R3, LONG R3 IGF-I, Recombinant Long R3 IGF-1

Molecular weight

9,117.5 Da

Research-grade purity

>99% HPLC

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

16 June 2026

What to know first

Long half-life variants are tools in cell biology rather than “recovery shortcuts” in humans.

Arg3 substitution eliminates IGFBP binding increasing free bioavailable IGF-1 approximately 3-fold

13-amino acid N-terminal extension enhances metabolic stability extending half-life to 20–30 hours

Full IGF-1R agonist activating PI3K/Akt/mTOR protein synthesis and RAS/RAF/MEK/ERK proliferation pathways

Bypasses hepatic GH/JAK2/STAT5 axis, direct peripheral tissue receptor activation

Details and limits sit in the sections below. Research use only.

What IGF-1 LR3 is

IGF-1 LR3 is investigated for IGF-receptor signalling, muscle cell culture work, and growth-factor cascades downstream of GH.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

IGF-1 LR3, 83-amino acid extended IGF-1 analogue with Arg3 substitution eliminating IGFBP binding for 3-fold enhanced potency and 20–30 hour half-life.

Quick takeaways

Long half-life variants are tools in cell biology rather than “recovery shortcuts” in humans.

Research contexts

Peer-reviewed papers discuss IGF-1 LR3 in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Cell-culture papers use LR3 variants to maintain IGF receptor stimulation across longer incubations, an assay convenience, not a human protocol.

Animal work may examine muscle regeneration models; results are species- and model-specific.

Muscle injury, overload or culture models of growth-factor cascades.

IGF/IGFBP biology in cell lines and animals. Signalling questions, not “gains”.

Arg3 substitution eliminates IGFBP binding increasing free bioavailable IGF-1 approximately 3-fold.

13-amino acid N-terminal extension enhances metabolic stability extending half-life to 20–30 hours.

Full IGF-1R agonist activating PI3K/Akt/mTOR protein synthesis and RAS/RAF/MEK/ERK proliferation pathways.

Bypasses hepatic GH/JAK2/STAT5 axis, direct peripheral tissue receptor activation.

Why Muscle / Performance research matters

Here the literature centres on muscle repair and growth-factor signalling after overload or injury in preclinical work.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

Arg3 substitution eliminates IGFBP binding increasing free bioavailable IGF-1 approximately 3-fold

13-amino acid N-terminal extension enhances metabolic stability extending half-life to 20–30 hours

Full IGF-1R agonist activating PI3K/Akt/mTOR protein synthesis and RAS/RAF/MEK/ERK proliferation pathways

Bypasses hepatic GH/JAK2/STAT5 axis, direct peripheral tissue receptor activation

Promotes hyperplasia (new muscle cell formation) and mitogenesis via satellite cell activation

Counteracts myostatin signaling through MyoD pathway activation in Duchenne muscular dystrophy models

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.

Research dosing context: Literature typically discusses 20–100 mcg subcutaneously or intramuscularly. Once daily, typically post-training or divided bilateral injections t½ ≈ 20–30 h (vs. 12–15 h for native IGF-1); enhanced bioavailability due to <2% IGFBP binding (vs. ~98% for native IGF-1); produced via recombinant E. coli expression with chromatographic purification and refolding. Not FDA-approved, mecasermin (native rhIGF-1) is approved for pediatric primary IGFD. Banned by WADA.

Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.

Purity check: Use the COA reading guide and the published IGF-1 LR3 Certificate of Analysis.

Common Questions People Are Asking

What is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino-acid analogue of human IGF-1 with an N-terminal extension and an Arg substitution at position 3. Those modifications stop it binding IGF-binding proteins, greatly extending its active half-life versus native IGF-1. It is supplied as a lyophilised research-grade powder for laboratory use only.

What does IGF-1 LR3 do?

In research models IGF-1 LR3 activates the IGF-1 receptor (and PI3K/Akt and MAPK signalling) to drive cell growth, proliferation, differentiation and survival — with a much longer duration of action than native IGF-1 because it evades IGFBP sequestration. These are findings in cell and animal models; New-U supplies it for laboratory research only and implies no human effect.

What is IGF-1 LR3 used for?

IGF-1 LR3 is widely used as a cell-culture supplement to support proliferation and survival of cultured cells, and as a research tool for studying IGF-1-receptor signalling, hypertrophy and tissue-growth endpoints. New-U supplies it strictly for in-vitro and laboratory research; it is not for human use.

Does IGF-1 LR3 show up on a drug test?

Standard employment or clinical drug panels (including typical LabCorp steroid panels) do not screen for IGF-1 LR3 — it is a peptide, not a small-molecule steroid, and requires specialised assays. It is, however, on the WADA Prohibited List, and anti-doping authorities use dedicated tests for IGF-1 analogues. New-U supplies IGF-1 LR3 for laboratory research only, not for human or athletic use.

What does "LR3" actually mean?

"L" for the 13-amino-acid N-terminal extension (MFPAMPLSSLFVN), "R" for arginine, and "3" for position 3 of the IGF-1 sequence. So "LR3" literally means "the Long variant with an Arginine at position 3". Both modifications are needed to eliminate IGFBP binding and extend circulating half-life.

How is IGF-1 LR3 different from IGF-1 DES?

IGF-1 DES is the opposite end of the design spectrum - a truncated 67-residue form missing the N-terminal tripeptide GPE, which also dramatically reduces IGFBP binding. IGF-1 LR3 uses a 13-residue extension to achieve similar IGFBP resistance. LR3 has a much longer half-life (20-30 h vs minutes); DES produces more intense, shorter-duration local effects when injected site-specifically.

Why is IGF-1 LR3 used in cell culture?

Native IGF-1 is inefficient in cell culture because IGFBPs produced by the cells themselves can sequester it, reducing effective concentrations. IGF-1 LR3 escapes that sequestration and delivers consistent, reproducible growth-factor signalling. That is why it is an industry standard for bioprocessing and mammalian cell culture.

How should IGF-1 LR3 be stored?

Keep the lyophilised powder frozen at −20 °C (−80 °C for long-term storage). After reconstitution, refrigerate at 1-6 °C and protect from light. IGF-1 LR3 is a structured protein and is sensitive to repeated freeze-thaw cycles - aliquot if you need multiple aliquots from one reconstitution.

How is IGF-1 LR3 reconstituted in the lab?

Because IGF-1 LR3 is a structured protein that tends to aggregate in neutral aqueous solution, laboratory practice commonly reconstitutes it in dilute acetic acid (around 0.1%, ~10 mM) rather than plain water, which keeps it in a non-aggregated state; bacteriostatic or sterile water is also used. The vial is allowed to reach room temperature before opening to avoid condensation, then gently rolled rather than shaken. This is general handling guidance for research material, not a dosing instruction.

Is this page medical advice? Can I use IGF-1 LR3 for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find IGF-1 LR3 specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside IGF-1 LR3.

PEG-MGF - companion guide

MGF - companion guide

TB-500 - companion guide

BPC-157 - companion guide

Scientific sources & further reading

Primary literature and registries for IGF-1 LR3, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on IGF-1 LR3

ClinicalTrials.gov: registered studies on IGF-1 LR3

IGF-1 LR3: Wikipedia

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: Long R3 IGF-1, Long Arginine 3 IGF-1, IGF-1 LR3, LR3-IGF-1, Insulin-Like Growth Factor 1 Long R3, LONG R3 IGF-I, Recombinant Long R3 IGF-1

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research

Support

Ways to Pay

Shop by goal

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Shop by compound

CJC-1295 (without DAC)

Shop by region

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.